This technology describes biosensors and methods of producing distal tips for biosensor transducers fur use in detecting one or more analytes selected from organic compounds susceptible to oxygenation and organophosphate compounds susceptible to hydrolysis.
It also sets forth methods of immobilizing the biocomponent to the distal tip, and methods of stabilizing the biocomponent in the tip.

This technology enables real-time, in situ, reagentless techniques for:
Environmental monitoring of the concentration and toxicity of contaminants (e.g., analytes, such as heavy metals, pesticides, etc.) in surface and groundwater, waste streams, and soil
Medical monitoring of routine blood, saliva and urine, using disposable one-way sensors
In vivo sensors for monitoring crucial parameters during surgery and other procedures
Food and drink contaminant detection, product content, monitoring of raw material conversion, and evaluation of product freshness
Process control, including the monitoring of pH, temperature, and substrate and dissolved gas concentrations in various processes (e.g., fermentation and microbial cell growth)
In the area of defense and security, measuring the presence of chemical warfare agents such as nerve gases, and detecting trace vapors, explosives, and drugs
Advantages of these distal tips and biosensors include:
This biosensor is portable, has a fast response time, and a low manufacturing cost, allowing for an excellent Return on Investment (ROI).
Enzymes are the preferred biocomponents of biosensors because they are catalytic, specific to a particular analyte, and fast-acting. The technology of this biosensor allows for the use of whole cells or isolated enzymes, and its methods of producing distal tips for the transducers enable detection of one or more analytes, simultaneously or sequentially.
Features of the distal tip include:
A biocomponent comprising at least one enzyme for carrying out a dehalogenation, oxidation, or hydrolysis of an analyte
Immobilization of the biocomponent to a surface of the tip by one or more of the following:
Treatment of the biocomponent for maintaining a period of enzymatic efficacy
Stabilization of the biocomponent
Peroxide Shunt
Development of enzymatic biosensors has been limited where NADH is required as a cofactor, because their long-term use and performance are limited due to problems encountered in supplying NADH. The peroxide shunt described in this patent may remove the need for NADH regeneration, which may increase biosensor lifetime since living cells are not required, where electrons and oxygen are supplied in the form of peroxide, and energy metabolism is no longer necessary.